<DOC>
	<DOCNO>NCT00383045</DOCNO>
	<brief_summary>A randomized clinical trial compare drug abuse HIV risk reduction counsel ( DC-HIV ) alone , DC-HIV combine naltrexone maintenance , DC-HIV combine buprenorphine maintenance treatment heroin addict Malaysia .</brief_summary>
	<brief_title>HIV Risk Reduction Drug Abuse Treatment Malaysia</brief_title>
	<detailed_description>Combining drug abuse HIV risk reduction counsel opioid agonist maintenance treatment ( OMT ) antagonist maintenance treatment naltrexone ( NMT ) effective reduce illicit drug use prevent HIV transmission associate heroin dependence , support NMT OMT remain tenuous many Western Pacific country ( e.g. , Malaysia , Indonesia Singapore ) heroin addiction HIV infection epidemic closely link due injection drug use ( IDU ) high-risk sexual behavior among addict . Promising result NMT Malaysia create interest evaluate OMT use buprenorphine ( BMT ) compare efficacy counsel alone counsel combine BMT NMT . This 24-week , randomize double blind clinical trial compare efficacy prevent heroin use relapse reduce HIV risk behavior manual-guided , HIV risk reduction drug counseling ( DC-HIV ) alone combine buprenorphine maintenance treatment ( BMT ) naltrexone maintenance treatment ( NMT ) recently detoxify currently abstinent heroin dependent patient ( N=180 ) Malaysia ( Specific Aim 1 ) . The study allow evaluation 3 hypothesis : DC-HIV plus naltrexone superior DC-HIV alone ; DC-HIV plus buprenorphine superior DC-HIV alone ; DC-HIV plus naltrexone superior DC-HIV plus buprenorphine . Primary outcome measure , assess 3x/wk urine toxicology test self-report , include resumption heroin use , 1 3 week continuous relapse reduction HIV risk behavior . The project also evaluate characteristic treatment-seeking heroin addict Malaysia ( include specific risk behavior pattern HIV risk behavior ; prevalence psychiatric medical comorbidity ; pattern social , family , vocational , criminal activity service needsâ€”Specific Aim 2 ) . This data use revise DC-HIV manual address specific circumstance risk behavior Malaysian heroin addict . Finally , project provide clinical train health professional train mentor drug abuse treatment HIV prevention research clinical researcher continue development , implementation , evaluation dissemination HIV prevention drug abuse treatment approach Malaysia project end ( Specific Aim 3 ) . The result study inform government policy support HIV prevention drug abuse treatment effort Malaysia possibly also Western Pacific country .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Opioid dependence Dependence alcohol , benzodiazepines sedative Suicide homicide risk Psychotic disorder major depression Inability read understand protocol assessment question Lifethreatening unstable medical problem Greater 3 time normal liver enzyme ( AST , GGT )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Buprenorphine</keyword>
	<keyword>Naltrexone</keyword>
	<keyword>HIV risk reduction behavior</keyword>
	<keyword>Counseling</keyword>
</DOC>